Growth Metrics

Verastem (VSTM) Cash & Equivalents Growth (3y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -51.77%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 24.73%
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -28.55%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 13.33%
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -16.07%
7 Evaxion A 64.16 Bn 64.14 Bn - 21.66%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -8.88%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 36.53%
10 Verastem 425.60 Mn 243.93 Mn 15.90 Mn 19.40%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 19.40%
Dec 31, 2025 37.37%
Sep 30, 2025 20.78%
Jun 30, 2025 36.97%
Mar 31, 2025 36.05%
Dec 31, 2024 5.90%
Sep 30, 2024 66.97%
Jun 30, 2024 49.46%
Mar 31, 2024 31.80%
Dec 31, 2023 4.75%
Sep 30, 2023 -17.71%
Jun 30, 2023 234.54%
Mar 31, 2023 -10.37%
Dec 31, 2022 22.03%
Sep 30, 2022 -8.88%
Jun 30, 2022 -17.30%
Mar 31, 2022 -20.10%
Dec 31, 2021 -16.80%
Sep 30, 2021 -42.92%
Jun 30, 2021 -47.10%
Mar 31, 2021 -17.92%
Dec 31, 2020 -6.22%
Sep 30, 2020 49.25%
Jun 30, 2020 -43.82%
Mar 31, 2020 68.60%
Dec 31, 2019 10.39%
Sep 30, 2019 40.47%
Jun 30, 2019 41.92%
Mar 31, 2019 82.14%
Dec 31, 2018 73.49%
Sep 30, 2018 87.50%
Jun 30, 2018 68.64%
Mar 31, 2018 28.70%
Dec 31, 2017 34.33%
Sep 30, 2017 35.61%
Jun 30, 2017 7.20%
Mar 31, 2017 28.62%
Dec 31, 2016 19.64%
Sep 30, 2016 18.08%
Jun 30, 2016 41.79%
Mar 31, 2016 -18.76%
Dec 31, 2015 35.05%
Sep 30, 2015 21.25%
Jun 30, 2015 30.71%
Mar 31, 2015 5.75%
Dec 31, 2014 0.00%
Sep 30, 2014 -20.83%
Jun 30, 2014 16.51%
Mar 31, 2014 69.55%